rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1987-6-2
|
pubmed:abstractText |
Tetanus toxoid purified by antibody-affinity chromatography, was compared with conventionally purified material in a double-blind trial in 205 healthy blood donors. There was neither any difference in immunogenicity as assessed by enzyme-linked immunoassay nor in side-reactions between the two vaccines. This study confirms that side-reactions to tetanus toxoid are not eliminated by purifying it.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0163-4453
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
119-24
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3553336-Adolescent,
pubmed-meshheading:3553336-Adult,
pubmed-meshheading:3553336-Chromatography, Affinity,
pubmed-meshheading:3553336-Clinical Trials as Topic,
pubmed-meshheading:3553336-Double-Blind Method,
pubmed-meshheading:3553336-Female,
pubmed-meshheading:3553336-Humans,
pubmed-meshheading:3553336-Male,
pubmed-meshheading:3553336-Middle Aged,
pubmed-meshheading:3553336-Tetanus Antitoxin,
pubmed-meshheading:3553336-Tetanus Toxoid,
pubmed-meshheading:3553336-Vaccination
|
pubmed:year |
1987
|
pubmed:articleTitle |
Double-blind comparative trial of standard (commercial) and antibody-affinity-purified tetanus toxoid vaccines.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|